Ireland[爱尔兰药品]

Viread 245 mg film-coated tabletsTenofovir disoproxil fumara

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-06-12 　查阅全文...

Noxafil 40 mg/ml oral suspensionPosaconazole

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-06-12 　查阅全文...

Zytiga 250 mg tablets

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-06-12 　查阅全文...

Copegus 200 mg film-coated tabletCopegus 400 mg film-coated

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-06-09 　查阅全文...

RoActemra 20 mg/ml concentrate for solution for infusion.toc

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-08 　查阅全文...

Bisolvon 4 mg/5 ml Oral SolutionBromhexine hydrochloride

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-06-07 　查阅全文...

Primovist 0.25 mmol/ml,solution for injection, pre-filled sy

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-07 　查阅全文...

Nitrolingual Pump Spray

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-06 　查阅全文...

ORENCIA 250 mg powder for concentrate for solution for infusion

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-06 　查阅全文...

ORENCIA 125 mg solution for injection (pre-filled syringe)

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-06 　查阅全文...

Vantas 50 mg implantHistrelin Acetate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-05 　查阅全文...

Nitrolingual Pumpspray 400 micrograms per metered dose, subl

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-05 　查阅全文...

Vimpat 50 mg film-coated tablets Vimpat 100 mg film-coated t

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-03 　查阅全文...

Lamictal 25 mg tablets.Lamictal 50 mg tablets.Lamictal 100 m

TbleofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration 4..

录入者：admin 发表于：2014-06-03 　查阅全文...

Lamictal 2 mg dispersible/chewable tablets.Lamotrigine

TbleofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration 4..

录入者：admin 发表于：2014-06-03 　查阅全文...

Lamictal 5 mg dispersible/chewable tablets.Lamictal 25 mg di

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-06-03 　查阅全文...

Zelboraf 240 mg Film-coated Tablets

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-06-03 　查阅全文...

SUTENT 12.5 mg hard capsulesSUTENT 25 mg hard capsulesSUTENT

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-05-29 　查阅全文...

Nexavar 200 mg film-coated tabletsSorafenib tosilate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-05-29 　查阅全文...

IRESSA 250 mg film-coated tabletsgefitinib

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..

录入者：admin 发表于：2014-05-29 　查阅全文...

首页上一页 46 47 48 49 50 51 52 下一页尾页 49/66/1301